G D Beretta Selected Research

Levoleucovorin

5/2011	Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial.
4/2004	High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G D Beretta Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 11/2000
6	Colorectal Neoplasms (Colorectal Cancer) 05/2011 - 11/2000
3	Colonic Neoplasms (Colon Cancer) 12/2007 - 07/2000
3	Rectal Neoplasms (Rectal Cancer) 02/2006 - 01/2001
3	Stomach Neoplasms (Stomach Cancer) 04/2004 - 01/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2003
1	Circulating Neoplastic Cells 01/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Discoid Lupus Erythematosus 07/2008
1	Neutropenia 10/2003
1	Alopecia (Baldness) 01/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2000

Drug/Important Bio-Agent (IBA)

10	Fluorouracil (Carac)FDA LinkGeneric 05/2011 - 11/2000
5	Leucovorin (Folinic Acid)FDA Link 12/2007 - 11/2000
5	Cisplatin (Platino)FDA LinkGeneric 04/2004 - 09/2000
4	Irinotecan (Camptosar)FDA LinkGeneric 05/2011 - 01/2001
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2007 - 11/2000
3	Capecitabine (Xeloda)FDA Link 07/2008 - 02/2006
2	Levoleucovorin FDA Link 05/2011 - 04/2004
2	Filgrastim (Neupogen)FDA Link 10/2003 - 01/2002
2	Gemcitabine FDA Link 02/2003 - 09/2000
1	Biological ProductsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Drug CombinationsIBA 01/2005
1	Methotrexate (Mexate)FDA LinkGeneric 10/2004
1	Glutathione (Reduced Glutathione)IBA 04/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2002
1	thiamine triphosphorate (TTP)IBA 11/2000
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2000

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2021 - 11/2000
3	Therapeutics 01/2021 - 01/2001
3	Adjuvant Chemotherapy 12/2007 - 07/2000
2	Radiotherapy 02/2006 - 01/2001
1	Treatment Delay 10/2003
1	Palliative Care (Palliative Therapy) 09/2001